These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27499189)

  • 1. Physiological Proteins in Therapeutics: A Current Review on Interferons.
    Ghosh D; Ghosh D; Parida P
    Mini Rev Med Chem; 2016; 16(12):947-52. PubMed ID: 27499189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of interferons in the socially important human viral diseases].
    Ospel'nikova TP
    Vopr Virusol; 2013; 58(5):4-10. PubMed ID: 24640164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of the interferon (IFN) in the therapy.
    Mahmutović S; Beslagić E
    Bosn J Basic Med Sci; 2004 Oct; 4(4):42-4. PubMed ID: 15628995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferons and their use in persistent viral infections.
    Chevaliez S; Pawlotsky JM
    Handb Exp Pharmacol; 2009; 189(189):203-41. PubMed ID: 19048202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viruses and interferons.
    Sen GC
    Annu Rev Microbiol; 2001; 55():255-81. PubMed ID: 11544356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interferon system in viral hepatitis].
    Lisker Melman M
    Rev Invest Clin; 1990 Jul; 42 Suppl():92-6. PubMed ID: 19256144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferons and autoimmune diseases].
    Niino M; Miyazaki Y
    Brain Nerve; 2013 Nov; 65(11):1381-8. PubMed ID: 24200616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The drug of first choice: interferon. Clinical pharmacological principles].
    Del Vecchio S; Dianzani F
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):81-7. PubMed ID: 7542487
    [No Abstract]   [Full Text] [Related]  

  • 9. [Etiological therapeutics in viral diseases].
    Brochier B; Thiry E; Wérenne J; Schwers A; Vindevogel H; Pastoret PP
    Ann Rech Vet; 1984; 15(1):35-54. PubMed ID: 6207760
    [No Abstract]   [Full Text] [Related]  

  • 10. [The interferons: pharmacology, mechanism of action, tolerance and side effects].
    Arnaud P
    Rev Med Interne; 2002 Nov; 23 Suppl 4():449s-458s. PubMed ID: 12481400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The first answer to viral infections: type I interferon].
    Pichlmair A; Pollak M; Bergthaler A
    Berl Munch Tierarztl Wochenschr; 2004; 117(7-8):252-65. PubMed ID: 15298051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem.
    Pinto EF; Andrade C
    Curr Neuropharmacol; 2016; 14(7):743-8. PubMed ID: 26733280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferons for viral hepatitis.
    Terrault N; Feinman SV
    Transfus Med Rev; 1995 Jan; 9(1):29-52. PubMed ID: 7536498
    [No Abstract]   [Full Text] [Related]  

  • 14. The biological basis for clinical use of interferon.
    Dianzani F; Antonelli G; Capobianchi MR
    J Hepatol; 1990; 11 Suppl 1():S5-10. PubMed ID: 1706739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interferons: physiology, pharmacology and pharmacotherapeutic perspectives].
    Billiau A
    J Pharmacol; 1983; 14 Suppl 3():105-16. PubMed ID: 6200731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon and its inducers--a never-ending story: "old" and "new" data in a new perspective.
    De Clercq E
    J Infect Dis; 2006 Sep; 194 Suppl 1(Suppl 1):S19-26. PubMed ID: 16921467
    [No Abstract]   [Full Text] [Related]  

  • 17. Alternative interferons and immunomodulators in the treatment of hepatitis C.
    Alao H; Jake Liang T
    Liver Int; 2014 Feb; 34 Suppl 1():133-8. PubMed ID: 24373090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon Control of Neurotropic Viral Infections.
    Milora KA; Rall GF
    Trends Immunol; 2019 Sep; 40(9):842-856. PubMed ID: 31439415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral applications of Toll-like receptor agonists.
    Horscroft NJ; Pryde DC; Bright H
    J Antimicrob Chemother; 2012 Apr; 67(4):789-801. PubMed ID: 22258929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of severe viral encephalitis with interferon and virostatic drugs].
    Prange HW; Weber T
    Med Klin (Munich); 1986 Oct; 81(21):657-62. PubMed ID: 2432387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.